HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug fails to impress in early head and neck cancer trial
Disease control TerminatedThis study tested the drug abemaciclib given for 10-21 days before surgery in people with HPV-negative head and neck cancer. The goal was to see if it could shrink tumors and was safe. Only 7 people took part before the study was stopped early.
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy for head and neck cancer shows promise but study halted early
Disease control TerminatedThis study tested whether adding danvatirsen to the standard immunotherapy pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has come back or spread. About 69 adults with incurable cancer were planned to join. The study was sto…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Flamingo Therapeutics NV • Aim: Disease control
Last updated May 11, 2026 20:54 UTC